Alkermes (ALKS) Current Assets (2011 - 2026)
Alkermes (ALKS) posted quarterly Current Assets of $1.5 billion for Q2 2026, down 6.87% year-over-year from $1.6 billion in Q2 2025, and up 12.09% quarter-over-quarter from $1.4 billion in Q1 2026.
Alkermes (ALKS) Current Assets (2011 - 2026) Analysis & Trends
Alkermes (ALKS) has reported Current Assets for 16 consecutive years, with $1.5 billion the latest figure, recorded in Q2 2026.
- In Q2 2026, Current Assets fell 6.87% year-over-year to $1.5 billion; the TTM figure through Jun 2026 stood at $1.5 billion (down 6.87% YoY), while the FY2025 annual figure was $1.9 billion, up 36.3% from the prior year.
- Current Assets rose to $1.5 billion in Q2 2026 per ALKS's latest filing, from $1.4 billion in the prior quarter.
- Across five years, Current Assets topped out at $1.9 billion in Q4 2025 and bottomed at $1.0 billion in Q1 2022.
- Historically, Current Assets has averaged $1.4 billion across 5 years, with a median of $1.5 billion in 2023.
- Annual changes were most pronounced in 2023 — Current Assets soared 39.0% — and 2026, when it decreased 8.14%.
- Alkermes' Current Assets stood at $1.1 billion in 2022, then soared by 31.43% to $1.5 billion in 2023, then fell by 4.72% to $1.4 billion in 2024, then surged by 36.3% to $1.9 billion in 2025, then declined by 21.06% to $1.5 billion in 2026.
- Business Quant data shows ALKS's Current Assets at $1.5 billion in Q2 2026, $1.4 billion in Q1 2026, and $1.9 billion in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.05 Bn | 43.08 Bn | - | 5.76 Bn |
| 2 | Teva Pharmaceutical Industries | 43.40 Bn | 39.75 Bn | 2.15 Bn | 13.76 Bn |
| 3 | Zoetis | 31.85 Bn | 30.18 Bn | 1.05 Bn | 6.36 Bn |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 19.76 Bn |
| 5 | United Therapeutics | 22.29 Bn | 19.63 Bn | 683.80 Mn | 3.48 Bn |
| 6 | Viatris | 18.76 Bn | 17.88 Bn | 1.46 Bn | 10.06 Bn |
| 7 | Neurocrine Biosciences | 15.68 Bn | 15.29 Bn | 935.80 Mn | 1.64 Bn |
| 8 | Elanco Animal Health | 11.87 Bn | 11.34 Bn | 798.00 Mn | 3.80 Bn |
| 9 | Dr Reddys Laboratories | 10.15 Bn | 9.99 Bn | - | 3.22 Bn |
| 10 | Alkermes | 8.19 Bn | 7.54 Bn | 397.90 Mn | 1.52 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.52 Bn |
| Mar 31, 2026 | 1.36 Bn |
| Dec 31, 2025 | 1.93 Bn |
| Sep 30, 2025 | 1.74 Bn |
| Jun 30, 2025 | 1.64 Bn |
| Mar 31, 2025 | 1.48 Bn |
| Dec 31, 2024 | 1.42 Bn |
| Sep 30, 2024 | 1.56 Bn |
| Jun 30, 2024 | 1.54 Bn |
| Mar 31, 2024 | 1.47 Bn |
| Dec 31, 2023 | 1.49 Bn |
| Sep 30, 2023 | 1.46 Bn |
| Jun 30, 2023 | 1.40 Bn |
| Mar 31, 2023 | 1.11 Bn |
| Dec 31, 2022 | 1.13 Bn |
| Sep 30, 2022 | 1.05 Bn |
| Jun 30, 2022 | 1.05 Bn |
| Mar 31, 2022 | 1.01 Bn |
| Dec 31, 2021 | 1.06 Bn |
| Sep 30, 2021 | 1.05 Bn |